As per the National Pharmaceutical Pricing Authority (NPPA), prices of 1,791 SKUs of scheduled drugs has come down during January this year following compliance of DPCO 2013.
Prices of 10,158 nonscheduled drugs have also declined during the period.
"As per a internal exercise conducted by NPPA to observe the price movement of medicines during the month of January, 2015 it was found that there was compliance of DPCO 2013 from pricing perspective in respect of 99.4 per cent of SKU's," NPPA said.
As per the findings of the exercise, NPPA found that there was decline of prices in respect to 11,949 SKU's out of which 1,791 were under the scheduled category while 10,158 were nonscheduled SKUs.
Further, in order to reign in certain instances of price violation by the manufacturers, NPPA said it will take necessary action in cases where price violation has been established under the provisions of DPCO 2013.
As per the NPPA, prices of 621 drugs were found to be hiked beyond permissible limits by some of the manufacturers.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
